301 related articles for article (PubMed ID: 25575036)
21. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract][Full Text] [Related]
22. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Gotlib J; Maxson JE; George TI; Tyner JW
Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
[TBL] [Abstract][Full Text] [Related]
23. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
Drexler HG; Nagel S; Quentmeier H
Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
[TBL] [Abstract][Full Text] [Related]
24. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
[TBL] [Abstract][Full Text] [Related]
25. Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N; Tefferi A
Blood Cancer J; 2018 Feb; 8(2):19. PubMed ID: 29440636
[TBL] [Abstract][Full Text] [Related]
26. Current Management of Chronic Neutrophilic Leukemia.
Szuber N; Tefferi A
Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138
[TBL] [Abstract][Full Text] [Related]
27. Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.
Carratt SA; Kong GL; Curtiss BM; Schonrock Z; Maloney L; Maniaci BN; Blaylock HZ; Baris A; Druker BJ; Braun TP; Maxson JE
Blood; 2022 Aug; 140(6):644-658. PubMed ID: 35482940
[TBL] [Abstract][Full Text] [Related]
28. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
Yin B; Chen X; Gao F; Li J; Wang HW
Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
[No Abstract] [Full Text] [Related]
29. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.
Carreño-Tarragona G; Álvarez-Larrán A; Harrison C; Martínez-Ávila JC; Hernández-Boluda JC; Ferrer-Marín F; Radia DH; Mora E; Francis S; González-Martínez T; Goddard K; Pérez-Encinas M; Narayanan S; Raya JM; Singh V; Gutiérrez X; Toth P; Amat-Martínez P; Mcilwaine L; Alobaidi M; Mayani K; McGregor A; Stuckey R; Psaila B; Segura A; Alvares C; Davidson K; Osorio S; Cutting R; Sweeney CP; Rufián L; Moreno L; Cuenca I; Smith J; Morales ML; Gil-Manso R; Koutsavlis I; Wang L; Mead AJ; Rozman M; Martínez-López J; Ayala R; Cross NCP
Blood Adv; 2023 May; 7(9):1672-1681. PubMed ID: 36375042
[TBL] [Abstract][Full Text] [Related]
30. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
[TBL] [Abstract][Full Text] [Related]
31. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review].
Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251
[TBL] [Abstract][Full Text] [Related]
32. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
Itonaga H; Ota S; Ikeda T; Taji H; Amano I; Hasegawa Y; Ichinohe T; Fukuda T; Atsuta Y; Tanizawa A; Kondo T; Miyazaki Y
Leuk Res; 2018 Dec; 75():50-57. PubMed ID: 30458320
[TBL] [Abstract][Full Text] [Related]
34. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
Mitsumori T; Komatsu N; Kirito K
Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
[TBL] [Abstract][Full Text] [Related]
35. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW
Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659
[TBL] [Abstract][Full Text] [Related]
36. Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
Baba Y; Nakamaki T; Sakai H; Fukuchi K; Kabasawa N; Hattori N; Harada H
Int J Hematol; 2023 Nov; 118(5):636-641. PubMed ID: 37439996
[TBL] [Abstract][Full Text] [Related]
37. Chronic neutrophilic leukaemia.
Uppal G; Gong J
J Clin Pathol; 2015 Sep; 68(9):680-4. PubMed ID: 26082513
[TBL] [Abstract][Full Text] [Related]
38. Chronic neutrophilic leukemia complicated with monoclonal gammopathy of undetermined significance: A case report and literature review.
Gao JP; Zhai LJ; Gao XH; Min FL
J Clin Lab Anal; 2022 Apr; 36(4):e24287. PubMed ID: 35170077
[TBL] [Abstract][Full Text] [Related]
39. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
[TBL] [Abstract][Full Text] [Related]
40. Chronic neutrophilic leukemia: a clinical perspective.
Menezes J; Cigudosa JC
Onco Targets Ther; 2015; 8():2383-90. PubMed ID: 26366092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]